Global Hemophilia Market By Type (Hemophilia A and Hemophilia B), By Treatment Type (On-Demand and Prophylaxis), By Therapy (Factor Replacement Therapy, Gene Therapy and Non-Factor Replacement Therapy), By Distribution Channel (Specialty Treatment Centers, Hospitals, Retail Pharmacies and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Jan 2026
- Report ID: 174531
- Number of Pages: 396
- Format:
-
keyboard_arrow_up
-
-
- Bayer AG
- Pfizer Inc.
- Novo Nordisk A/S
- Takeda Pharmaceutical Company Limited
- Bioverativ (Sanofi)
- Sobi (Swedish Orphan Biovitrum AB)
- CSL Behring
- Octapharma AG
- Grifols, S.A.
- Shire (now part of Takeda)
Our Clients
Kickstart 2026 with Exclusive Savings
✖
Request a Sample Report
We'll get back to you as quickly as possible